|
1
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Egawa S, Toma H, Ohigashi H, Okusaka T,
Nakao A, Hatori T, Maguchi H, Yanagisawa A and Tanaka M: Japan
pancreatic cancer registry; 30th year anniversary: Japan pancreas
society. Pancreas. 41:985–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luo J, Xiao L, Wu C, Zheng Y and Zhao N:
The incidence and survival rate of population-based pancreatic
cancer patients: Shanghai Cancer Registry 2004–2009. PLoS One.
8:e760522013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boon RA, Jae N, Holdt L and Dimmeler S:
Long non-coding RNAs: From clinical genetics to therapeutic
targets? J Am Coll Cardiol. 67:1214–1226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu MT, Hu JW, Yin R and Xu L: Long
non-coding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang X, Zhi X, Gao Y, Ta N, Jiang H and
Zheng J: LncRNAs in pancreatic cancer. Oncotarget. 7:57379–57390.
2016.PubMed/NCBI
|
|
8
|
Peng W, Gao W and Feng J: Long non-coding
RNA HULC is a novel biomarker of poor prognosis in patients with
pancreatic cancer. Med Oncol. 31:3462014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhan HX, Wang Y, Li C, Xu JW, Zhou B, Zhu
JK, Han HF, Wang L, Wang YS and Hu SY: LincRNA-ROR promotes
invasion, metastasis and tumor growth in pancreatic cancer through
activating ZEB1 pathway. Cancer Lett. 374:261–271. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheng Y, Jutooru I, Chadalapaka G, Corton
JC and Safe S: The long non-coding RNA HOTTIP enhances pancreatic
cancer cell proliferation, survival and migration. Oncotarget.
6:10840–10852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu JH, Chen G, Dang YW, Li CJ and Luo DZ:
Expression and prognostic significance of lncRNA MALAT1 in
pancreatic cancer tissues. Asian Pac J Cancer Prev. 15:2971–2977.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan
Z and Ai K: H19 promotes pancreatic cancer metastasis by
derepressing let-7's suppression on its target HMGA2-mediated EMT.
Tumour Biol. 35:9163–9169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qu S, Yang X, Song W, Sun W, Li X, Wang J,
Zhong Y, Shang R, Ruan B, Zhang Z, et al: Downregulation of
lncRNA-ATB correlates with clinical progression and unfavorable
prognosis in pancreatic cancer. Tumour Biol. 37:3933–3938. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smola MJ, Christy TW, Inoue K, Nicholson
CO, Friedersdorf M, Keene JD, Lee DM, Calabrese JM and Weeks KM:
SHAPE reveals transcript-wide interactions, complex structural
domains, and protein interactions across the Xist lncRNA in living
cells. Proc Natl Acad Sci USA. 113:pp. 10322–10327. 2016;
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tantai J, Hu D, Yang Y and Geng J:
Combined identification of long non-coding RNA XIST and HIF1A-AS1
in serum as an effective screening for non-small cell lung cancer.
Int J Clin Exp Pathol. 8:7887–7895. 2015.PubMed/NCBI
|
|
17
|
Yao Y, Ma J, Xue Y, Wang P, Li Z, Liu J,
Chen L, Xi Z, Teng H, Wang Z, et al: Knockdown of long non-coding
RNA XIST exerts tumor-suppressive functions in human glioblastoma
stem cells by up-regulating miR-152. Cancer Lett. 359:75–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL,
Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding
RNA XIST regulates gastric cancer progression by acting as a
molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin
Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fang J, Sun CC and Gong C: Long non-coding
RNA XIST acts as an oncogene in non-small cell lung cancer by
epigenetically repressing KLF2 expression. Biochem Biophys Res
Commun. 478:811–817. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhuang LK, Yang YT, Ma X, Han B, Wang ZS,
Zhao QY, Wu LQ and Qu ZQ: MicroRNA-92b promotes hepatocellular
carcinoma progression by targeting Smad7 and is mediated by long
non-coding RNA XIST. Cell Death Dis. 7:e22032016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hayes EL and Lewis-Wambi JS: Mechanisms of
endocrine resistance in breast cancer: An overview of the proposed
roles of non-coding RNA. Breast Cancer Res. 17:402015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Ann Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Muluhngwi P and Klinge CM: Roles for
miRNAs in endocrine resistance in breast cancer. Endocr Relat
Cancer. 22:R279–R300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Filipska M, Skrzypski M, Bigda JJ and
Jassem J: Biological role of prognostic microRNAs (miRNAs) in
squamous lung cancer cell lines. J Thorac Oncol. 10:S391. 2015.
|
|
25
|
Kara M, Yumrutas O, Ozcan O, Celik OI,
Bozgeyik E, Bozgeyik I and Tasdemir S: Differential expressions of
cancer-associated genes and their regulatory miRNAs in colorectal
carcinoma. Gene. 567:81–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang P, Zuo Z, Wu A, Shang W, Bi R, Jin
Q, Wu J and Jiang L: miR-600 inhibits cell proliferation, migration
and invasion by targeting p53 in mutant p53-expressing human
colorectal cancer cell lines. Oncol Lett. 13:1789–1796. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ergun S and Oztuzcu S: Oncocers:
ceRNA-mediated cross-talk by sponging miRNAs in oncogenic pathways.
Tumour Biol. 36:3129–3136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su X, Xing J, Wang Z, Chen L, Cui M and
Jiang B: microRNAs and ceRNAs: RNA networks in pathogenesis of
cancer. Chin J Cancer Res. 25:235–239. 2013.PubMed/NCBI
|
|
29
|
Guo LL, Song CH, Wang P, Dai LP, Zhang JY
and Wang KJ: Competing endogenous RNA networks and gastric cancer.
World J Gastroenterol. 21:11680–11687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi
Y and Guo J: Long non-coding RNA associated-competing endogenous
RNAs in gastric cancer. Sci Rep. 4:60882014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiao C, Song Z, Chen J, Zhong J, Cai W,
Tian S, Chen S, Yi Y and Xiao Y: LncRNA-UCA1 enhances cell
proliferation through functioning as a ceRNA of Sox4 in esophageal
cancer. Oncol Rep. 36:2960–2966. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia T, Chen S, Jiang Z, Shao Y, Jiang X,
Li P, Xiao B and Guo J: Long non-coding RNA FER1L4 suppresses
cancer cell growth by acting as a competing endogenous RNA and
regulating PTEN expression. Sci Rep. 5:134452015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Alzheimer's Association, . 2013
Alzheimer's disease facts and figures. Alzheimers Dement.
9:208–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Malvezzi M, Bertuccio P, Levi F, La
Vecchia C and Negri E: European cancer mortality predictions for
the year 2013. Ann Oncol. 24:792–800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
No authors listed: Cancer statistics JAMA.
310:9822013.
|
|
41
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li X, Deng SJ, Zhu S, Jin Y, Cui SP, Chen
JY, Xiang C, Li QY, He C, Zhao SF, et al: Hypoxia-induced
lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic
cancer by derepressing the miR-3923/KRAS pathway. Oncotarget.
7:6000–6014. 2016.PubMed/NCBI
|
|
45
|
Müller S, Raulefs S, Bruns P, Afonso-Grunz
F, Plötner A, Thermann R, Jäger C, Schlitter AM, Kong B, Regel I,
et al: Next-generation sequencing reveals novel differentially
regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic
cancer. Mol Cancer. 14:942015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ye S, Yang L, Zhao X, Song W, Wang W and
Zheng S: Bioinformatics method to predict two regulation mechanism:
TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer. Cell
Biochem Biophys. 70:1849–1858. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jiao F, Hu H, Yuan C and Wang L, Jiang W,
Jin Z, Guo Z and Wang L: Elevated expression level of long
non-coding RNA MALAT-1 facilitates cell growth, migration and
invasion in pancreatic cancer. Oncol Rep. 32:2485–2492. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lian Y, Wang J, Feng J, Ding J, Ma Z, Li
J, Peng P, De W and Wang K: Long non-coding RNA IRAIN suppresses
apoptosis and promotes proliferation by binding to LSD1 and EZH2 in
pancreatic cancer. Tumour Biol. 37:14929–14937. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zheng S, Chen H, Wang Y, Gao W, Fu Z, Zhou
Q, Jiang Y, Lin Q, Tan L, Ye H, et al: Long non-coding RNA
LOC389641 promotes progression of pancreatic ductal adenocarcinoma
and increases cell invasion by regulating E-cadherin in a
TNFRSF10A-related manner. Cancer Lett. 371:354–365. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sullivan CS and Ganem D: MicroRNAs and
viral infection. Mol Cell. 20:3–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Staedel C and Darfeuille F: MicroRNAs and
bacterial infection. Cell Microbiol. 15:1496–1507. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kato M, Castro NE and Natarajan R:
MicroRNAs: Potential mediators and biomarkers of diabetic
complications. Free Radic Biol Med. 64:85–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Filipowicz W: RNAi: The nuts and bolts of
the RISC machine. Cell. 122:17–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li
Y, Li Z, Ng SS, Sung JJ, et al: miR-34a-5p suppresses colorectal
cancer metastasis and predicts recurrence in patients with stage
II/III colorectal cancer. Oncogene. 34:4142–4152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pu Y, Zhao F, Wang H, Cai W, Gao J, Li Y
and Cai S: MiR-34a-5p promotes the multi-drug resistance of
osteosarcoma by targeting the CD117 gene. Oncotarget.
7:28420–28434. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Pu Y, Zhao F, Li Y, Cui M, Wang H, Meng X
and Cai S: The miR-34a-5p promotes the multi-chemoresistance of
osteosarcoma via repression of the AGTR1 gene. BMC Cancer.
17:452017. View Article : Google Scholar : PubMed/NCBI
|
